K. Yacouben

Growth deceleration in children treated with imatinib for chronic myeloid leukaemia.

A. Baruchel, T. Leblanc, Y. Bertrand, 2014, European journal of cancer.

Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial.

J. Cayuela, A. Baruchel, T. Leblanc, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neuroinflammatory Disease following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children

N. Boddaert, Shen-Ying Zhang, I. Desguerre, 2022, The Journal of Pediatrics.

Neuroinflammatory Disease following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children

N. Boddaert, Shen-Ying Zhang, I. Desguerre, 2022, The Journal of Pediatrics.

Rituximab therapy for childhood Evans syndrome

A. Pariente, C. Picard, F. Ledeist, 2007, Haematologica.

Improved outcome with pulses of Vincristine (VCR) and Steroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and Non Hodgkin Lymphoma (NHL): final report of the EORTC randomized phase III trial 58951

Y. Bertrand, A. Uyttebroeck, S. Suciu, 2008 .

How can cobalamin injections be spaced in long-term therapy for inborn errors of vitamin B(12) absorption?

M. Schiff, S. Lebon, O. Fenneteau, 2012, Molecular genetics and metabolism.

Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral pre-emptive treatment.

A. Baruchel, S. Chevret, J. Dalle, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Results of a Phase II Trial Testing Interferon Alpha 2b and Cytarabine in Children with Chronic Myelogenous Leukemia.

G. Leverger, T. Leblanc, F. Guilhot, 2004 .

Neuroinflammatory Disease following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children

N. Boddaert, Shen-Ying Zhang, I. Desguerre, 2022, The Journal of Pediatrics.

Imatinib Is Efficient but Has a Negative Impact On Growth in Children with Previously Untreated chronic Myelogenous Leukaemia (CML) in Early Chronic Phase (CP): Results of the French National Phase IV Trial.

J. Cayuela, A. Baruchel, T. Leblanc, 2009 .

Improved Outcome with Pulses of Vincristine and Steroids in Continuation Therapy of Children with Average Risk Acute Lymphoblastic Leukemia (ALL) and Non Hodgkin Lymphoma (NHL): Final Report of the EORTC Randomized Phase III Trial 58951

Y. Bertrand, A. Uyttebroeck, S. Suciu, 2008 .